(Q42519496)

1 November 2017

title

Vismodegib: a guide to its use in locally advanced or metastatic basal cell carcinoma (English)

1 reference

Katherine A Lyseng-Williamson

1 November 2017

author

series ordinal

1

object named as

Katherine A Lyseng-Williamson

1 reference

1 November 2017

2

Gillian M Keating

1 reference

1 November 2017

publication date

1 February 2013

1 reference

American Journal of Clinical Dermatology

1 November 2017

published in

1 reference

1 November 2017

volume

14

1 reference

1 November 2017

issue

1

1 reference

1 November 2017

page(s)

61-64

1 reference

https://scigraph.springernature.com/pub.10.1007/s40257-012-0004-6

1 November 2017

exact match

0 references

cites work

Assessing current treatment options for patients with severe/advanced basal cell carcinoma

1 reference

https://api.crossref.org/works/10.1007%2FS40257-012-0004-6

Hedgehog signaling: networking to nurture a promalignant tumor microenvironment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40257-012-0004-6

Phase I trial of hedgehog pathway inhibitor vismodegib (GDC-0449) in patients with refractory, locally advanced or metastatic solid tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40257-012-0004-6

GDC-0449-a potent inhibitor of the hedgehog pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40257-012-0004-6

Inhibition of the hedgehog pathway in advanced basal-cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40257-012-0004-6

Efficacy and safety of vismodegib in advanced basal-cell carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40257-012-0004-6

Vismodegib: in locally advanced or metastatic basal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40257-012-0004-6

10.1007/S40257-012-0004-6

21 January 2018

Identifiers

DOI

1 reference

1 November 2017

1 reference